RA MEDICAL SYSTEMS INC (RMED) Stock Price & Overview
NYSEARCA:RMED • US74933X3026
Current stock price
The current stock price of RMED is 0.594 USD. Today RMED is up by 10%. In the past month the price decreased by -13.28%. In the past year, price decreased by -92.68%.
RMED Key Statistics
- Market Cap
- 4.163M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -45.97
- Dividend Yield
- N/A
RMED Stock Performance
RMED Stock Chart
RMED Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to RMED. When comparing the yearly performance of all stocks, RMED is a bad performer in the overall market: 98.09% of all stocks are doing better.
RMED Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to RMED. RMED scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
RMED Earnings
RMED Forecast & Estimates
7 analysts have analysed RMED and the average price target is 7.14 USD. This implies a price increase of 1102.02% is expected in the next year compared to the current price of 0.594.
For the next year, analysts expect an EPS growth of 52.85% and a revenue growth 13964.3% for RMED
RMED Groups
Sector & Classification
RMED Financial Highlights
Over the last trailing twelve months RMED reported a non-GAAP Earnings per Share(EPS) of -45.97. The EPS increased by 73.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
RMED Ownership
RMED Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.91 | 178.754B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.23 | 160.562B | ||
| SYK | STRYKER CORP | 21.92 | 126.877B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.96 | 93.218B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.9 | 47.074B | ||
| IDXX | IDEXX LABORATORIES INC | 38.42 | 45.348B | ||
| BDX | BECTON DICKINSON AND CO | 11.33 | 43.995B | ||
| RMD | RESMED INC | 18.25 | 32.645B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.61 | 32.062B | ||
| DXCM | DEXCOM INC | 24.47 | 23.946B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.72 | 17.783B | ||
| HOLX | HOLOGIC INC | 15.41 | 16.888B | ||
| PODD | INSULET CORP | 31.6 | 14.383B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About RMED
Company Profile
Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. The company is headquartered in Fort Mill, South Carolina and currently employs 14 full-time employees. The company went IPO on 2018-09-27. The firm is focused on developing technology for electrophysiology (EP) procedures. The Company’s product includes Ventricular Onset System (VIVO), LockeT and Amigo Remote Catheter System. Its VIVO is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its VIVO utilizes non-invasive inputs to locate the origin of ventricular arrhythmias. VIVO uses standard clinical inputs, such as a CT or MRI and a 12 lead ECG, both of which are routinely gathered for EP procedures, allowing VIVO to seamlessly integrate into the workflow. A 3D photograph is obtained of the patient’s torso after the ECG leads are in place and all of these clinical inputs are combined to generate a 3D map of the patient’s heart with a location of the earliest onset of the ventricular arrhythmia.
Company Info
IPO: 2018-09-27
RA MEDICAL SYSTEMS INC
1670 Highway 160 West, Suite 205
Fort Mill SOUTH CAROLINA 92011 US
CEO: Jonathan Will McGuire
Employees: 14
Phone: 19736912000.0
RA MEDICAL SYSTEMS INC / RMED FAQ
Can you describe the business of RA MEDICAL SYSTEMS INC?
Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. The company is headquartered in Fort Mill, South Carolina and currently employs 14 full-time employees. The company went IPO on 2018-09-27. The firm is focused on developing technology for electrophysiology (EP) procedures. The Company’s product includes Ventricular Onset System (VIVO), LockeT and Amigo Remote Catheter System. Its VIVO is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its VIVO utilizes non-invasive inputs to locate the origin of ventricular arrhythmias. VIVO uses standard clinical inputs, such as a CT or MRI and a 12 lead ECG, both of which are routinely gathered for EP procedures, allowing VIVO to seamlessly integrate into the workflow. A 3D photograph is obtained of the patient’s torso after the ECG leads are in place and all of these clinical inputs are combined to generate a 3D map of the patient’s heart with a location of the earliest onset of the ventricular arrhythmia.
What is the current price of RMED stock?
The current stock price of RMED is 0.594 USD. The price increased by 10% in the last trading session.
Does RMED stock pay dividends?
RMED does not pay a dividend.
How is the ChartMill rating for RA MEDICAL SYSTEMS INC?
RMED has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of RMED stock?
RA MEDICAL SYSTEMS INC (RMED) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Can you provide the growth outlook for RA MEDICAL SYSTEMS INC?
The Revenue of RA MEDICAL SYSTEMS INC (RMED) is expected to grow by 13964.3% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for RA MEDICAL SYSTEMS INC?
RA MEDICAL SYSTEMS INC (RMED) has a market capitalization of 4.16M USD. This makes RMED a Nano Cap stock.